Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Paramagnetic relaxation enhancement is a process where paramagnetic metal ions (commonly Gadolinium(III), iron, manganese, copper, among others) catalyze the magnetic relaxation of water protons, thereby increasing the rate at which the protons return to equilibrium after excitation in magnetic resonance imaging (MRI). This phenomenon is exploited by MRI contrast agents, which consist of chelated metal ions that transiently interact with bulk water, enhancing image contrast by shortening proton relaxation times (T1, T2). The efficiency depends on factors such as distance between water and metal, correlation time, electronic properties of the ion, exchange rates, and molecular interactions of the complex. The process itself is not a biological target, but compounds that exploit it are clinically important as imaging agents.
Paramagnetic-induced acceleration of water proton T1 and/or T2 relaxation (through dipole–dipole interactions and/or scalar contact interaction between unpaired electrons and protons)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Paramagnetic metal complex.